Figure 10.
Graphical outline of the study on SLC-0111+dacarbazine/temozolomide/DOX/5-fluorouracil combination reported by Andreucci et al. [69].
Graphical outline of the study on SLC-0111+dacarbazine/temozolomide/DOX/5-fluorouracil combination reported by Andreucci et al. [69].